Clinical Trial

Secretin in Ex-situ Liver Perfusion

Name: Secretin in Ex-situ Liver Perfusion — clinical trial record (NCT07651748)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 1/2

View on ClinicalTrials.gov →

Summary

The main objective is to assess whether the use of human synthetic secretin in a clinical (COR-)NMP procedure can restore physiological HCO3- content of the bile during ex-situ NMP.

Trial Details

NCT Number	NCT07651748
Lead Sponsor	Erasmus Medical Center
Conditions	Liver Transplantation
Enrollment	20 participants
Start Date	2025-04-26
Primary Completion	2026-06 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-06-16